Abstract 4552: Preclinical characterization of BMS-986218, a novel nonfucosylated anti–CTLA-4 antibody designed to enhance antitumor activityJohn Engelhardt, Karen Price, Natalie Bezman et al.|Cancer Research|2020Cited by 11
Abstract 4551: Preclinical characterization of novel anti-CTLA-4 prodrug antibodies with an enhanced therapeutic indexJohn Engelhardt, Karen Price, Rahima Akter et al.|Cancer Research|2020Cited by 6